Article Details
Retrieved on: 2024-01-08 19:31:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Harpoon's lead experimental treatment, HPN328, uses T-cell engagers to trigger an immune system response to attack cancer cells in patients ...
Article found on: www.investopedia.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here